Search Results - "Taniwaki, Leticia"

Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing by Cassoli, Janaina Pontes Batista, Fernandes, Ítalo, Carvalho, Leonardo, Fernandes, Milena, Centrone, Ana Fernanda, Taniwaki, Letícia, Lima, Rita de Cássia, Junior, Uelson Donizeti Rocioli, Dias, Igor Wanderley Reis, Taranto, Patrícia, Beal, Juliana, de Lima, Fernanda Teresa, Moura, Fernando, Cendoroglo, Miguel, Araújo, Sergio Eduardo Alonso, Uson Junior, Pedro Luiz Serrano

“…HER2-Low is defined as low levels of HER2 expression, based on a score of 1+ on immunohistochemical (IHC) assay or as an IHC score of 2+ and negative results…”
Get full text

Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis by Uson Junior, Pedro Luiz Serrano, Carvalho, Leonardo, Fernandes, Milena Lourenço Coleta, Botrus, Gehan, de Souza Martins, Rodrigo, da Silva, Elaine Ferreira, dos Santos, Sarah Silva Mello Batista, Taniwaki, Leticia, Taranto, Patrícia, Dutra, Ana Carolina Pereira, de Oliveira Filho, João Bosco, Araujo, Sergio Eduardo Alonso, Moura, Fernando

“…Neoadjuvant chemotherapy is considered a new treatment option for potentially resectable pancreatic cancer. However, data are not well established on overall…”
Get full text

Timing of palliative care access and outcomes of advanced cancer patients referred to an inpatient palliative care consultation team in Brazil by Taniwaki, Letícia, Serrano Usón Junior, Pedro Luiz, Rodrigues de Souza, Polianna Mara, Lobato Prado, Bernard

“…Little is known about the outcomes of cancer patients referred to palliative care (PC) teams in developing countries. Our aim was to examine the timing of PC…”
Get more information

Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study by Castro, Nicoly Marques de, Moura, Fernando, Hada, Aline Lury, Garcia, Diogo, Victor, Elivane da Silva, Schvartsman, Gustavo, Carvalho, Leonardo, Fernandes, Milena Lourenço Coleta, Martins, Rodrigo de Souza, Silva, Elaine Ferreira da, Santos, Sarah Silva Mello Batista Dos, Taniwaki, Letícia, Taranto, Patrícia, Pontes, Janaina, Beal, Juliana Rodrigues, Dutra, Ana Carolina Pereira, Oliveira Filho, João Bosco de, Araujo, Sérgio Eduardo Alonso, Usón Junior, Pedro Luiz Serrano

“…Currently programmed cell death protein 1 (PD-1) inhibitors in combination with other therapies are being evaluated to determine their efficacy in cancer…”
Get full text